SFX by Ex Libris Inc.

Title:	Rescue of a Drosophila NF1 mutant phenotype by protein kinase A
Source:	Science [0036-8075] The, I yr:1997

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Guo, H F F. "A neurofibromatosis-1-regulated pathway is required for learning in Drosophila." Nature 403.6772 (2000): 895-8.
description	2.	Chong, H. "Mechanisms of regulating the Raf kinase family." Cellular signalling 15.5 (2003): 463-469.
description	3.	Uemura, T. "Age-dependent deterioration of locomotion in Drosophila melanogaster deficient in the homologue of amyotrophic lateral sclerosis 2." Genes to cells 19.6 (2014): 464-477.
description	4.	Nuwal, T. "Mass spectrometric analysis of synapsins in Drosophila melanogaster and identification of novel phosphorylation sites." Journal of proteome research 10.2 (2011): 541-550.
description	5.	Bernards, A. "Reduced growth of Drosophila neurofibromatosis 1 mutants reflects a non-cell-autonomous requirement for GTPase-Activating Protein activity in larval neurons." Genes & development 20.23 (2007): 3311-23.
description	6.	Costa, Rui M M. "Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1." Nature 415.6871 (2002): 526-530.
description	7.	Sacks, D.B. B. "The role of scaffold proteins in MEK/ERK signalling." Biochemical society transactions 34.5 (2006): 833-6.
description	8.	Gouzi, Jean Y. "The receptor tyrosine kinase Alk controls neurofibromin functions in Drosophila growth and learning." PLOS Genetics 7.9 (2011).
description	9.	Guo, H F F. "Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides." Science 276.5313 (1997): 795-798.
description	10.	North, K N N. "Cognitive function and academic performance in neurofibromatosis 1: Consensus statement from the NF1 cognitive disorders task force." Neurology 48.4 (1997): 1121-1127.
description	11.	Dasgupta, B. "Neurofibromatosis 1: closing the GAP between mice and men." Current opinion in genetics & development 13.1 (2003): 20-7.
description	12.	Meunier, B. "Respiratory complex III dysfunction in humans and the use of yeast as a model organism to study mitochondrial myopathy and associated diseases." Biochimica et biophysica acta. Bioenergetics 1827.11/12 (2012): 1346-1361.
description	13.	Srikanth, S. "Functional Properties of the Drosophila melanogaster Inositol 1,4,5-Trisphosphate Receptor Mutants." Biophysical journal 86.6 (2004): 3634-3646.
description	14.	Ge, F. "Phosphoproteomic analysis of primary human multiple myeloma cells." Journal of Proteomics 73.7 (2010): 1381-1390.
description	15.	Sun, W. "Genetic Interaction between Neurexin and CAKI/CMG Is Important for Synaptic Function in Drosophila Neuromuscular Junction." Neuroscience research 64.4 (2009): 362-371.
description	16.	Allada, R. "Perturbing dynamin reveals potent effects on the Drosophila circadian clock." PloS one 4.4 (2009).
description	17.	Schoeberl, B. "Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors." Nature biotechnology 20.4 (2002): 370-375.
description	18.	Gallo, Kathleen A A. "Mixed-lineage kinase control of JNK and p38 MAPK pathways." Nature reviews. Molecular cell biology 3.9 (2002): 663-72.
description	19.	Trovisco, V. "B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas." Human pathology 37.7 (2006): 781-6.
description	20.	Li, W. "The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1." Current biology 15.21 (2005): 1961-1967.